Search - tctmd.com

Displaying 961 - 980 of 981

Sort: Relevancy | Date

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Daily News

Registry Shows Better Survival for Women vs. Men After TAVR

Caitlin E. Cox

July 19, 2012

News Daily News

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

L.A. McKeown

July 18, 2012

News Daily News

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

Caitlin E. Cox

June 21, 2012

News Daily News

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

Jason Kahn

June 18, 2012

Presentation TVT 2012

Overview of Large Hole Transfemoral and Transapical Access-Closure Devices

Presenter: Martin Leon

June 05, 2012

Presentation TVT 2012

Overview of Cerebral Protection Devices

Presenter: Eberhard Grube

June 05, 2012

Presentation TVT 2012

Embrella Deflector Device: Introducing PROTAVI

Presenter: Alec Vahanian

June 04, 2012

Presentation TVT 2012

Claret Montage Filter Device: Early Clinical Experiences

Presenter: Eberhard Grube

June 04, 2012

Presentation TVT 2012

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Presenter: Josep Rodes-Cabau

June 04, 2012

Presentation TVT 2012

Percutaneous 'Large Hole' Vascular Access-Closure Devices

Presenter: Martin Leon

June 04, 2012

Presentation TVT 2012

Novel Trans-apical Access-Closure Devices

Presenter: Michael Mack

June 04, 2012

Presentation TVT 2012

Complication of a Cerebral Protection Device

Presenter: 204222|Ronald Binder

June 02, 2012

Presentation TCTAP 2012

Transcatheter Aortic Valve Implantation with Balloon and Self Expandable Devices: Results from the Milan Registry

Presenter: Alaide Chieffo

April 26, 2012

Presentation GI2 2012

How to Improve TAVR Safety? The Role of Ancillary Devices

Presenter: Martin B. Leon

April 12, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

CME

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

CME

New Clinical Data on TAVR use and Intermediate Risk Patients

CME

Advertisement

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

Registry Shows Better Survival for Women vs. Men After TAVR

Need for Permanent Pacemaker Uncommon After Sapien Valve Implantation

Permanent Pacemaker After TAVR Does Not Worsen Hard Outcomes

TAVR Achieves Positive Short-term Outcomes in Bicuspid Valves

Overview of Large Hole Transfemoral and Transapical Access-Closure Devices

Overview of Cerebral Protection Devices

Embrella Deflector Device: Introducing PROTAVI

Claret Montage Filter Device: Early Clinical Experiences

Will Cerebral Embolic Protection Devices Reduce Strokes After TAVR?

Percutaneous 'Large Hole' Vascular Access-Closure Devices

Novel Trans-apical Access-Closure Devices

Complication of a Cerebral Protection Device

Transcatheter Aortic Valve Implantation with Balloon and Self Expandable Devices: Results from the Milan Registry

How to Improve TAVR Safety? The Role of Ancillary Devices

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

New Clinical Data on TAVR use and Intermediate Risk Patients

TAVR Evolves: Are You and the Heart Team Ready?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content